Barclays’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
424,248
+143,613
| +51% | +$671K | ﹤0.01% | 2236 |
|
|
2025
Q1 | $1.54M | Sell |
280,635
-67,007
| -19% | -$368K | ﹤0.01% | 2211 |
|
|
2024
Q4 | $1.18M | Buy |
347,642
+23,170
| +7% | +$78.5K | ﹤0.01% | 2538 |
|
|
2024
Q3 | $925K | Buy |
324,472
+151,685
| +88% | +$432K | ﹤0.01% | 2660 |
|
|
2024
Q2 | $389K | Sell |
172,787
-32,186
| -16% | -$72.5K | ﹤0.01% | 2682 |
|
|
2024
Q1 | $453K | Sell |
204,973
-70,990
| -26% | -$157K | ﹤0.01% | 2897 |
|
|
2023
Q4 | $648K | Buy |
275,963
+170,220
| +161% | +$400K | ﹤0.01% | 2859 |
|
|
2023
Q3 | $197K | Buy |
105,743
+13,040
| +14% | +$24.3K | ﹤0.01% | 3043 |
|
|
2023
Q2 | $242K | Sell |
92,703
-47,029
| -34% | -$123K | ﹤0.01% | 2994 |
|
|
2023
Q1 | $229K | Buy |
139,732
+31,421
| +29% | +$51.5K | ﹤0.01% | 3069 |
|
|
2022
Q4 | $144K | Buy |
108,311
+47,566
| +78% | +$63.2K | ﹤0.01% | 3266 |
|
|
2022
Q3 | $95K | Buy |
60,745
+31,151
| +105% | +$48.7K | ﹤0.01% | 3438 |
|
|
2022
Q2 | $46K | Buy |
29,594
+7,806
| +36% | +$12.1K | ﹤0.01% | 3762 |
|
|
2022
Q1 | $56K | Buy |
+21,788
| New | +$56K | ﹤0.01% | 3956 |
|
|
2021
Q4 | – | Sell |
-29,541
| Closed | -$72K | – | 3868 |
|
|
2021
Q3 | $72K | Buy |
29,541
+24,418
| +477% | +$59.5K | ﹤0.01% | 3313 |
|
|
2021
Q2 | $21K | Sell |
5,123
-33,627
| -87% | -$138K | ﹤0.01% | 3713 |
|
|
2021
Q1 | $174K | Buy |
38,750
+23,747
| +158% | +$107K | ﹤0.01% | 3180 |
|
|
2020
Q4 | $74K | Sell |
15,003
-6,107
| -29% | -$30.1K | ﹤0.01% | 3065 |
|
|
2020
Q3 | $126K | Buy |
21,110
+532
| +3% | +$3.18K | ﹤0.01% | 2947 |
|
|
2020
Q2 | $55K | Buy |
20,578
+9,174
| +80% | +$24.5K | ﹤0.01% | 3369 |
|
|
2020
Q1 | $22K | Sell |
11,404
-15,288
| -57% | -$29.5K | ﹤0.01% | 3364 |
|
|
2019
Q4 | $188K | Buy |
26,692
+13,153
| +97% | +$92.6K | ﹤0.01% | 3203 |
|
|
2019
Q3 | $133K | Sell |
13,539
-3,651
| -21% | -$35.9K | ﹤0.01% | 3248 |
|
|
2019
Q2 | $197K | Buy |
17,190
+11,104
| +182% | +$127K | ﹤0.01% | 3209 |
|
|
2019
Q1 | $61K | Buy |
6,086
+5,244
| +623% | +$52.6K | ﹤0.01% | 3561 |
|
|
2018
Q4 | $15K | Sell |
842
-1,636
| -66% | -$29.1K | ﹤0.01% | 3463 |
|
|
2018
Q3 | $44K | Buy |
+2,478
| New | +$44K | ﹤0.01% | 3775 |
|